INTERSECT ENT INC - COM (XENT)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
29,588,366
Share change
-826,365
Total reported value
$828,680,356
Price per share
$28.01
Number of holders
128
Value change
-$21,859,710
Number of buys
66
Number of sells
49

Institutional Holders of INTERSECT ENT INC - COM (XENT) as of Q1 2022

As of 31 Mar 2022, INTERSECT ENT INC - COM (XENT) was held by 128 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,588,366 shares. The largest 10 holders included Versor Investments LP, BlackRock Inc., Magnetar Financial LLC, VANGUARD GROUP INC, ALPINE ASSOCIATES MANAGEMENT INC., STATE STREET CORP, Melqart Asset Management (UK) Ltd, Westchester Capital Management, LLC, GOLDMAN SACHS GROUP INC, and MORGAN STANLEY. This page lists 128 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.